| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |